Suppr超能文献

COVID-19 期间脓毒症和肺炎的趋势:来自 BPCIA 的经验教训。

Trends in sepsis and pneumonia during COVID-19: lessons from BPCIA.

机构信息

Association of American Medical Colleges, 655 K St NW, Ste 100, Washington, DC 20001. Email:

出版信息

Am J Manag Care. 2023 Mar;29(3):125-131. doi: 10.37765/ajmc.2023.89327.

Abstract

OBJECTIVES

The COVID-19 pandemic affected care delivery nationwide for all patients, influencing cost and utilization for patients both with and without COVID-19. Our first analysis assessed changes in utilization for patients with sepsis without COVID-19 prior to vs during the pandemic. Our second analysis assessed cost and utilization changes during the pandemic for patients with sepsis or pneumonia both with and without COVID-19.

STUDY DESIGN

A retrospective case-control study was utilized to determine differences in cost and utilization for patients with sepsis or pneumonia, relative to a COVID-19 diagnosis.

METHODS

Claims data from 8 teaching hospitals participating in sepsis and pneumonia episodes in the Bundled Payments for Care Improvement Advanced (BPCIA) model were utilized. BPCIA is a Medicare value-based care bundled payment program that aims to decrease costs and increase quality of care through a 90-day total cost of care model.

RESULTS

The first analysis (N = 1092) found that non-COVID-19 patients with sepsis had 26% higher hospice utilization (P < .05) and 38% higher mortality (P < .0001) during the pandemic vs the prepandemic period. The second analysis (N = 640) found that during the pandemic, patients with sepsis or pneumonia with COVID-19 had 70% more skilled nursing facility (SNF) use (P < .0001), 132% higher SNF costs (P < .0001), and 21% higher total episode costs (P < .0001) compared with patients without COVID-19.

CONCLUSIONS

COVID-19 has affected care patterns for all patients. Patients without COVID-19 postponed care and used lower-acuity care settings, whereas patients with COVID-19 were more costly and utilized postacute care at a higher rate. These analyses inform future care coordination initiatives, given the ongoing pandemic.

摘要

目的

COVID-19 大流行影响了全国所有患者的医疗服务提供,影响了 COVID-19 患者和非 COVID-19 患者的成本和利用。我们的第一项分析评估了大流行前和大流行期间非 COVID-19 脓毒症患者利用情况的变化。第二项分析评估了 COVID-19 患者和非 COVID-19 患者脓毒症或肺炎患者在大流行期间的成本和利用变化。

研究设计

利用回顾性病例对照研究来确定 COVID-19 诊断相关的脓毒症或肺炎患者的成本和利用差异。

方法

利用参与脓毒症和肺炎发作的 8 家教学医院的索赔数据,参与捆绑支付改善高级(BPCIA)模式的脓毒症和肺炎发作。BPCIA 是一项医疗保险基于价值的护理捆绑支付计划,旨在通过 90 天的总成本护理模型来降低成本和提高护理质量。

结果

第一项分析(N=1092)发现,大流行期间非 COVID-19 脓毒症患者的临终关怀使用率增加了 26%(P<.05),死亡率增加了 38%(P<.0001)。第二项分析(N=640)发现,大流行期间 COVID-19 患者的脓毒症或肺炎患者使用了 70%更多的熟练护理设施(SNF)(P<.0001),SNF 成本增加了 132%(P<.0001),总发作成本增加了 21%(P<.0001),与无 COVID-19 的患者相比。

结论

COVID-19 影响了所有患者的护理模式。无 COVID-19 的患者推迟了治疗,使用了低急症护理环境,而 COVID-19 患者的成本更高,并且更频繁地使用后期护理。鉴于大流行仍在继续,这些分析为未来的护理协调计划提供了信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验